Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines
Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
A PHASE4 clinical study on Hepatitis and Hepatitis B, this trial is completed. The trial is conducted by Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León and has accumulated 15 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
15 versions recorded-
Feb 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Feb 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
▶ Show 10 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE4
-
Sep 2021 — Dec 2021 [monthly]
Completed PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Completed PHASE4
-
Dec 2019 — Jan 2021 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2019 — Dec 2019 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Mar 2019 — Sep 2019 [monthly]
Recruiting PHASE4
-
Jan 2019 — Mar 2019 [monthly]
Recruiting PHASE4
-
Nov 2018 — Jan 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2018 — Jun 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
- Instituto de Investigación Biomédica de Salamanca
- Spanish Clinical Research Network - SCReN
For direct contact, visit the study record on ClinicalTrials.gov .